VG Life Sciences Competitors and Similar CompaniesClear all
VG Life Sciences's competitors and similar companies include Epizyme and Syndax Pharmaceuticals.
 VG Life Sciences VG Life Sciences (VGLS, also known as SB Technology Holdings, formerly Viral Genetics) is a company that develops therapeutic and diagnostic pharmaceutical and medical products. |  Epizyme Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors. |  Syndax Pharmaceuticals Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy. | |
Founding Date | Founding Date 1995 | Founding Date 2007 | Founding Date 2005 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations New York, US HQ | Locations Cambridge, US HQ | Locations Waltham, US HQ New York, US Waltham, US |
Employees | Employees 1 | Employees 20364% increase | Employees 358% decrease |
Valuation ($) | Valuation ($) 2.1 m | Valuation ($) 250.8 m | Valuation ($) 1.6 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $37.4m (FY, 2021) | Revenue (est.) $172.4m (FY, 2025) |
Net income | Net income ($6.2m) (FY, 2014) | Net income ($251.1m) (FY, 2021) | Net income ($285.4m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 2.8m | Total funding raised $ 51.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Epizyme
HQ
Cambridge, US
Employees
203
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
View companySyndax Pharmaceuticals
HQ
Waltham, US
Employees
35↓ 8% decrease
Syndax Pharmaceuticals is a late-stage clinical development oncology company focused on overcoming the problem of resistance in cancer therapy.
View company